SCHEMBL786853

SCHEMBL786853

CCCCCCCCCCCCCCCCCC[Si](C)(CCCCCC(=O)O)O[Si](C)(CCCCCCCCCCCCCCCCCC)CCCC(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.50
FFAR1 O14842 2/20 0.50
GPR84 Q9NQS5 7/20 0.47
PPARG P37231 7/20 0.47
PPARD Q03181 7/20 0.47
PPARA Q07869 7/20 0.47
HDAC11 Q96DB2 5/20 0.47
TSHR P16473 4/20 0.47
PTPN1 P18031 3/20 0.47
ALDH1A1 P00352 2/20 0.47
TLR2 O60603 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
FABP4 P15090 2/20 0.47
KMT2A Q03164 2/20 0.47
ALOX15 P16050 2/20 0.47
HSD17B10 Q99714 2/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
MEN1 O00255 1/20 0.47
ESR1 P03372 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonanoate SCHEMBL23581109 0.82 FFAR4 (0.72) FFAR4FFAR1GPR84PPARGPPARD
Nonanoate SCHEMBL1761102 0.82 FFAR4 (0.67) FFAR4FFAR1GPR84PPARGPPARD
Pentadecanoic Acid SCHEMBL27576651 0.82 FFAR4 (0.72) FFAR4FFAR1GPR84PPARGPPARD
Stearic Acid SCHEMBL28748860 0.82 FFAR4 (0.72) FFAR4FFAR1GPR84PPARGPPARD
Heptanoate SCHEMBL20838480 0.82 FFAR4 (0.67) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL919433 0.77 FFAR4 (0.66) FFAR4FFAR1GPR84PPARGPPARD
Hexanoate SCHEMBL1645486 0.77 AKR1B1 (0.64) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL3811423 0.75 CYP1A2 (0.67) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL21998 0.75 CYP1A2 (0.67) FFAR4FFAR1GPR84PPARGPPARD
Pimelic Acid SCHEMBL8471838 0.75 CYP1A2 (0.67) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166342-A1 Functionalized Matrices for Dispersion of Nanostructures NANOSYS, INC. (US) 2015-06-18 US disclosed
US-8916064-B2 Functionalized matrices for dispersion of nanostructures NANOSYS, INC. (US) 2014-12-23 US disclosed
US-20140151600-A1 Functionalized Matrices for Dispersion of Nanostructures NANOSYS, INC. (US) 2014-06-05 US disclosed
US-20130043433-A1 Functionalized Matrixes for Dispersion of Nanostructures NANOSYS, INC. (US) 2013-02-21 US disclosed
US-20120068118-A1 NANOCRYSTAL DOPED MATRIXES SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068118-A1 NANOCRYSTAL DOPED MATRIXES STRA6, EPHA6, PIR FFAR4 4863/4885FFAR1 4876/4885GPR84 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.